ZIM Laboratories Limited (ZIMLAB.BO)

INR 113.15

(0.85%)

Market Cap (In INR)

5.51 Billion

Revenue (In INR)

3.67 Billion

Net Income (In INR)

172.46 Million

Avg. Volume

54.69 Thousand

Currency
INR
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
89.9-131.3
PE
-
EPS
-
Beta Value
0.566
ISIN
INE518E01015
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Dr. Chandrashekhar Mainde
Employee Count
-
Website
https://www.zimlab.in
Ipo Date
2018-06-11
Details
ZIM Laboratories Limited develops, manufactures, and supplies generic pharmaceutical and nutraceutical products in India and internationally. The company provides its products in pre- formulation intermediates and finished formulations using modified release patterns in the oral solid dosage forms, such as granules, pellets, taste-masked powders, suspensions, tablets, capsules, dry syrup, and oral thin films. It offers therapeutics in the areas of urology, gastroenterology, CNS, antibiotics, anti-infectives, NSAIDs/pain analgesics, and vitamins and supplements. ZIM Laboratories Limited was incorporated in 1984 and is based in Nagpur, India.